These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11731334)

  • 1. Autologous lymphocyte-monocyte co-culture increases NMR-visible and cytoplasmic lipids in the absence of increased markers of lymphocyte activation.
    Delikatny EJ; van Holst Pellekaan CJ; King NJ
    Biochim Biophys Acta; 2001 Oct; 1533(3):243-54. PubMed ID: 11731334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.
    Baran J; Kowalczyk D; Ozóg M; Zembala M
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):303-13. PubMed ID: 11238213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The generation of 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C.
    Veale MF; Roberts NJ; King GF; King NJ
    Biochem Biophys Res Commun; 1997 Oct; 239(3):868-74. PubMed ID: 9367861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand.
    Nüsslein HG; Frosch KH; Woith W; Lane P; Kalden JR; Manger B
    Eur J Immunol; 1996 Apr; 26(4):846-50. PubMed ID: 8625977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells.
    Di Vito M; Lenti L; Knijn A; Iorio E; D'Agostino F; Molinari A; Calcabrini A; Stringaro A; Meschini S; Arancia G; Bozzi A; Strom R; Podo F
    Biochim Biophys Acta; 2001 Jan; 1530(1):47-66. PubMed ID: 11341958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulation of activation antigens on human lymphocytes by beta-estradiol.
    Komlos L; Zahavi Z; Dicker D; Luria D; Salman H; Zahavi I
    Am J Reprod Immunol; 1998 Dec; 40(6):418-23. PubMed ID: 9894566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
    Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
    J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
    Vandenberghe P; Ceuppens JL
    Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of arctigenin on lymphocyte activation stimulated with PMA/ionomycin.
    Sun CH; Lai XQ; Zhang L; Yao JC; Guan YX; Pan LH; Yan Y
    Yao Xue Xue Bao; 2014 Apr; 49(4):482-9. PubMed ID: 24974465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell activation responses are differentially regulated during clinorotation and in spaceflight.
    Hashemi BB; Penkala JE; Vens C; Huls H; Cubbage M; Sams CF
    FASEB J; 1999 Nov; 13(14):2071-82. PubMed ID: 10544190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking.
    Kindler V; Matthes T; Jeannin P; Zubler RH
    Eur J Immunol; 1995 May; 25(5):1239-43. PubMed ID: 7539752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of four trichothecene mycotoxins on activation marker expression and cell proliferation of human lymphocytes in culture.
    Johannisson A; Bjökhag B; Hansson W; Gadhasson IL; Thuvander A
    Cell Biol Toxicol; 1999; 15(4):203-15. PubMed ID: 10696820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H-NMR visible neutral lipids in activated T lymphocytes: relationship to phosphatidylcholine cycling.
    Veale MF; Dingley AJ; King GF; King NJ
    Biochim Biophys Acta; 1996 Oct; 1303(3):215-21. PubMed ID: 8908156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-inflammatory effect of the SOCC blocker SK&F 96365 on mouse lymphocytes after stimulation by Con A or PMA/ionomycin.
    Ye Y; Zhang Y; Lu X; Huang X; Zeng X; Lai X; Zeng Y
    Immunobiology; 2011 Sep; 216(9):1044-53. PubMed ID: 21470712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.
    Kahi S; Cozon GJ; Greenland T; Wallon M; Gay-Andrieu F; Peyron F
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):745-8. PubMed ID: 9801328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R.
    Hedfors IA; Brinchmann JE
    Scand J Immunol; 2003 Nov; 58(5):522-32. PubMed ID: 14629624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.